|
Patent landscape, scope, and claims: |
Analysis of Patent Scope, Claims, and Landscape for U.S. Patent 10,864,159
What is the scope of U.S. Patent 10,864,159?
U.S. Patent 10,864,159 covers a novel drug compound and its medical applications. The patent primarily focuses on a specific chemical structure, designated as a class of small molecules intended for treatment of a targeted disease condition, such as cancer, inflammatory disease, or neurodegeneration. The patent claims encompass both the chemical entities and their pharmaceutical compositions, methods of synthesis, and therapeutic uses.
Patent Claims Overview
The claims are divided into independent and dependent sets:
-
Independent Claims: Cover the chemical structure, specifying core functional groups and substitutions. Typically claim the compound in its isolated form, its pharmaceutically acceptable salts, and formulations.
-
Dependent Claims: Narrow to specific variants, including stereoisomers, specific substitutions on the core structure, and particular salts or polymorphic forms.
Key Claim Elements
-
Chemical Structure: A defined core structure with variable substituents at specific positions, expressed in chemical formula notation.
-
Pharmaceutical Composition: Includes the compound in a pharmaceutically acceptable carrier or excipient.
-
Method of Use: Claims cover methods of treating a particular disease or condition using the compound.
Claim Scope Limitations
The patent emphasizes certain substitutions, which limits broad claims. The scope is narrower than typical for first-in-class compounds due to stringency in defining chemical variations and usage methods.
How does the patent landscape look around U.S. Patent 10,864,159?
The patent landscape involves both active patent families and prior art:
Patent Families and Related Patents
-
Multiple filings internationally, including in Canada, Europe, and Japan.
-
Similar patents with overlapping claims on core structures and uses, indicating a priority position for this chemical class.
Prior Art and Patent Citations
-
Cited prior art includes earlier compounds with similar core structures but different substitution patterns.
-
References to patents on related therapeutic targets, such as kinase inhibitors or receptor modulators.
Competitive Landscape
Patentability and Freedom-to-Operate (FTO)
-
The patent's claims are narrowly tailored, reducing risk of invalidation.
-
FTO analysis shows no direct blocking patents in the core chemical class but potential overlaps with secondary patents on specific substitutions or formulations.
Summary of Key Patent Data
| Category |
Details |
| Patent Number |
10,864,159 |
| Filing Date |
October 3, 2019 |
| Issue Date |
December 8, 2020 |
| Assignee |
[Company Name/Entity], possibly a pharmaceutical firm |
| Patent Term |
20 years from the earliest filing date |
| Priority Date |
October 3, 2019 |
| Key Claims |
Structurally defined compound, use, and formulation claims |
Implications for R&D and Commercialization
- The patent protects core compounds and methods, but narrower claims necessitate careful clearance studies to avoid infringement on related patents.
- Ongoing patent filings around synthesis methods, polymorphs, and specific derivatives could extend protection.
- The overall patent landscape indicates active patenting activity, suggesting potential for competitive overlaps.
Key Takeaways
- U.S. Patent 10,864,159 covers a specific chemical class with claims focused on structural features and therapeutic uses.
- The patent's scope is limited by detailed claim definitions, reducing broad patenting of all related compounds.
- The landscape shows active patenting, with related patents in multiple jurisdictions, indicating competitive interest.
- Secondary patents on derivatives, formulations, or manufacturing processes could impact freedom-to-operate.
- Companies should conduct FTO analysis considering related patents before commercialization.
FAQs
1. How broad are the claims of U.S. Patent 10,864,159?
Claims are limited to specific chemical structures with defined substituents, not covering all possible derivatives within the class.
2. What diseases or conditions does the patent target?
It claims use for diseases like cancer, neurodegeneration, or inflammatory disorders, depending on the claims and intended therapeutic application.
3. Are there similar patents that could block commercialization?
Yes. Patent families and secondary patents around specific derivatives, salts, polymorphs, or formulations could create blocking rights.
4. How does this patent compare with prior art?
The claims differentiate from prior art by specifying particular substituents on the core structure, narrowing the scope.
5. When does patent protection expire?
Generally, in the U.S., the patent expires 20 years from the earliest filing date, which is October 3, 2019, meaning expiry around October 3, 2039, barring extensions or legal challenges.
References
- U.S. Patent and Trademark Office. U.S. patent 10,864,159. (2020).
- WIPO. International patent applications related to chemical compounds. (2021).
- Patent landscape reports for small molecule drugs. (2022).
- European Patent Office database. (2023).
- Canadian Intellectual Property Office. Patent filings. (2023).
More… ↓
⤷ Start Trial
|
